News - Page 531

TLDR: CV Pad is a new launchpad that gives casual investors access to expertly vetted and VC-curated investment opportunities in the web3 and blockchain space. The collaboration between CV VC, CV Labs,

TLDR: Investors at the Natural Products Expo West discuss the state of funding for CPG startups, highlighting the importance of profitability and the potential for investment from large CPG companies in the

Article Summary TLDR: Key Points: Channel 4 is launching Untapped, a new initiative to invest in overlooked founders. Untapped aims to diversify founder profiles based on factors like gender, education, race, and

TLDR: Michael Brown is a partner at Shield Capital and is involved in various defense technology initiatives. The Department of Defense has introduced a new industrial strategy aimed at revitalizing the defense

TLDR: Isaac Kato, former leader of Techstars Seattle, has launched a new venture firm called Two Ravens to support “non-obvious” founders. Two Ravens aims to invest in diverse founders, immigrant founders, and

TLDR: Immutable launches $100 million fund for blockchain games, called the “Inevitable Games Fund” (IGF) IGF invests in seven blockchain game titles, including Pixelmon, Guild of Guardians, Metalcore, and My Pet Hooligan

TLDR: Key Points: Most VC track records are not exemplary, with the Top 20 VCs earning the majority of VC returns. Corporate VCs face constraints but can succeed by developing unicorn-entrepreneurs and

TLDR: – Marc Andreessen and his wife are selling their $33.37 million mansion in Atherton, California – The couple is moving to Southern California after acquiring over $250 million worth of properties

Article Summary TLDR: Marco raises $12 million in Series A funding to expand solutions for Latin American SME exporters. The company plans to develop additional products to support its current user base.

TLDR: Key Points: CAR-T industry has raised over $128.25 billion through various funding deals 170 companies worldwide are developing CAR-T products and therapies In recent years, the CAR-T industry has seen a